A multicenter, randomized, controlled trial of interferon alfacon-1 compared with α-2a-interferon in Chinese patients with chronic hepatitis C virus infection

Journal of Gastroenterology and Hepatology (Australia)

Volumn 15, Issue 10, 2000, Pages 1165-1170

  Yao, Guang Bi ^a,g   Fu, Xi Xian ^b   Tian, Geng Shan ^b   Xu, Dao Zhen ^c   Hao, Lian Jie ^d   Huangfu, Yu Shan ^e   Su, Chun Xin ^f  

^a Shanghai Jing An Qu Central Hospital   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e BEIJING 302 HOSPITAL   (China)

^f CAPITAL MEDICAL UNIVERSITY   (China)

^g NONE   (China)

Author keywords

Alanine aminotransferase; Consensus interferon; End of treatment response; Genotype; Hepatitis C virus RNA; Interferon 2a interferon alfacon 1; Predictive factors; Sustained response

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2A INTERFERON; CONSENSUS INTERFERON;

ADULT; ARTICLE; CHINESE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0033710621     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2000.02307.x     Document Type: Article

References (17)

1. Viral hepatitis in China: Seroepidemiological survey in Chinese population (Part one: 1992-5)
2. Natural history of hepatitis C
3. Therapy of hepatitis C: Overview
4. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration
5. A comparison of interferon-Con 1 with natural recombinant interferon-α: Antiviral, antiproliferative, and natural killer-inducing activities
6. The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon
7. A proposed system for the nomenclature of hepatitis C viral genotypes
8. Classification of chronic hepatitis: Diagnosis, grading and staging
9. World Health Organization Criteria
10. Therapy of hepatitis C: Consensus interferon trials
11. Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trial
12. Re-treatment of chronic hepatitis C with consensus interferon
13. Factors predictive of a beneficial response to therapy of hepatitis C
14. Hepatitis C virus infection and genotypes
15. HCV genotypes distribution in chronic hepatitis C infection patients from Shanghai region
16. Long-term efficacy of recombinant interferon alpha 2a in the treatment of chronic hepatitis C: A randomized prospective study comparing two dose schedules in Chinese patients
17. A randomized, double-blind, controlled trial of consensus interferon in the treatment of Chinese patients with chronic hepatitis C